Leifras Co Ltd ADRLFS
Price$2.10

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $74.8M0.0% YoYTTM through 31 Dec 2025
Net Income $2.8M0.0% YoYTTM through 31 Dec 2025
Free Cash Flow $2.7MTTM through 31 Dec 2025

Margins

Current
Gross Margin32.2%
EBITDA Margin6.4%
Operating Margin5.4%
Net Margin3.7%

Returns

23.7%ROE
9.4%ROA
-87.4%ROIC

Balance Sheet Health

Debt / Equity0.10x
Current Ratio1.54x
Net Debt-$15Mnet cash position
Cash & Equivalents$16.1M

Quality Metrics

Altman Z-Score5.35
FCF Margin3.6%

Multi-Year Trend

Revenue
'23'24'25
FY2025: $11.7B
Diluted EPS$0.11TTM
'23'24'25
FY2025: $17.40

Dividend

No dividend

Capital Allocation

Capex Intensity0.4%
Financials converted at 156.4130 from JPY.
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.